Elevated Levels of Urinary Podocyte-Derived Microparticles in Nephrotic Syndrome
Abstract
BACKGROUND: Nephrotic syndrome (NS) is the most common glomerular disease in childhood. The proposed hypothesis for the pathogenesis of this disease has changed over time, from immune dysregulation theory and systemic circulating factors theory, to the growing recognition of podocytopathies’ role. The existance of podocytopathies is usually examined by using podocyte-derived microparticles (MPs), such as nephrin, podocin, and podocalyxin (PCX). Therefore in this study, the difference between nephrin, podocin, and PCX expressions in NS children and healthy children was investigated.
METHODS: An observational cross-sectional study was conducted, involving 33 children with NS and 22 age-matched healthy children as controls. Urine samples were collected from each subject in the early morning, before being processed and incubated with antibodies to detect nephrin, podocin, and PCX. The processed samples were then analyzed with flow cytometer methods.
RESULTS: NS subjects had significantly higher expression of all three urinary podocyte-derived MPs compared to the control subjetcs. Nephrin, podocin, and PCX showed good discrimination in NS subjects with the area under curve (AUC) of 0.895, 0.849, and 0.728, respectively.
CONCLUSION: This study revealed the differential expression of podocyte proteins in NS subjects compared to healthy controls. This supports the role of podocytopathies in the pathogenesis of NS. Therefore, nephrin, podocin, and PCX might have potentials to be future non-invasive diagnostic tools in glomerular disease.
KEYWORDS: nephrin, nephrotic syndrome, podocalyxin, podocin, podocyte, urinary microparticle
Full Text:
PDFReferences
Noone DG, Iijima K, Parekh R. Idiopathic nephrotic syndrome in children. Lancet. 2018; 392(10141): 61–74, CrossRef.
Downie ML, Gallibois C, Parekh RS, Noone DG. Nephrotic syndrome in infants and children: Pathophysiology and management. Paediatr Int Child Health. 2017; 37(4): 248–58, CrossRef.
Arif E, Nihalani D. Glomerular filtration barrier assembly: An insight. Postdoc J. 2013; 1(4): 33–45, CrossRef.
Wanner N, Hartleben B, Herbach N, Goedel M, Stickel N, Zeiser R, et al. Unraveling the role of podocyte turnover in glomerular aging and injury. J Am Soc Nephrol. 2014; 25(4): 707–16, CrossRef.
Garg P. A Review of podocyte biology. Am J Nephrol. 2018; 47(Suppl 1): 3–13, CrossRef.
Sekulic M, Pichler Sekulic S. A compendium of urinary biomarkers indicative of glomerular podocytopathy. Patholog Res Int. 2013; 2013: 782395, CrossRef.
Hara M, Yanagihara T, Kihara I, Higashi K, Fujimoto K, Kajita T. Apical cell membranes are shed into urine from injured podocytes: A novel phenomenon of podocyte injury. J Am Soc Nephrol. 2005; 16(2): 408–16, CrossRef.
May CJ, Saleem M, Welsh GI. Podocyte dedifferentiation: A specialized process for a specialized cell. Front Endocrinol. 2014; 5: 148. doi: 10.3389/fendo.2014.00148, CrossRef.
Engelmann C, Splith K, Krohn S, Herber A, Boehlig A, Boehm S, et al. Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: A cohort study. J Transl Med. 2017; 15(1): 188, CrossRef.
Meiliana A, Wijaya A. Microparticles novel mechanisms of intracellular communication: Implication in health and disease. Indones Biomed J. 2011; 3(1): 18–36, CrossRef.
Lu J, Hu ZB, Chen PP, Lu CC, Zhang JX, Li XQ, et al. Urinary podocyte microparticles are associated with disease activity and renal injury in systemic lupus erythematosus. BMC Nephrol. 2019; 20(1): 303, CrossRef.
Muhari-Stark E, Burckart GJ. Glomerular filtration rate estimation formulas for pediatric and neonatal use. J Pediatr Pharmacol Ther. 2018; 23(6): 424–31, CrossRef.
Kriz W, Hackenthal E, Nobiling R, Sakai T, Elger M, Hähnel B. A role for podocytes to counteract capillary wall distension. Kidney Int. 1994; 45(2): 369–76, CrossRef.
Nielsen JS, McNagny KM. The role of podocalyxin in health and disease. J Am Soc Nephrol. 2009; 20(8): 1669–76, CrossRef.
Refaeli I, Hughes MR, Wong AKW, Bissonnette MLZ, Roskelley CD, Wayne Vogl A, et al. Distinct functional requirements for podocalyxin in immature and mature podocytes reveal mechanisms of human kidney disease. Sci Rep. 2020; 10(1): 9419, CrossRef.
Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, et al. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest. 2001; 108(11): 1621–9, CrossRef.
Saleem MA, Ni L, Witherden I, Tryggvason K, Ruotsalainen V, Mundel P, et al. Co-localization of nephrin, podocin, and the actin cytoskeleton: Evidence for a role in podocyte foot process formation. Am J Pathol. 2002; 161(4): 1459–66, CrossRef.
Sun D, Zhao X, Meng L. Relationship between urinary podocytes and kidney diseases. Ren Fail. 2012; 34(3): 403–7, CrossRef.
Guan N, Ding J, Zhang J, Yang J. Expression of nephrin, podocin, α-actinin, and WT1 in children with nephrotic syndrome. Pediatr Nephrol. 2003; 18(11): 1122–7, CrossRef.
Koop K, Eikmans M, Baelde HJ, Kawachi H, De Heer E, Paul LC, et al. Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol. 2003; 14(8): 2063–71, CrossRef.
Agrawal V, Prasad N, Jain M, Pandey R. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria. Clin Exp Nephrol. 2013; 17(6): 811–8, CrossRef.
Wang P, Li M, Liu Q, Chen B, Ji Z. Detection of urinary podocytes and nephrin as markers for children with glomerular diseases. Exp Biol Med. 2015; 240(2): 169–74, CrossRef.
Vogelmann SU, Nelson WJ, Myers BD, Lemley KV. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol. 2003; 285(1): F40–8, CrossRef.
Jiang WL, Peng YM, Liu YH, Liu H, Chen GC, Xu XQ, et al. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression. Ren Fail. 2012; 34(7): 821–6, CrossRef.
Perez-hernandez J, Olivares MD, Forner MJ, Chaves FJ, Cortes R. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis. 2016; 31(5): 780–9, CrossRef.
Abou Ghanima AT, Almaghraby MF, Elsaadany HM, Hosny MA, Kumar RK. Urinary podocalyxin and nephrin levels as biomarkers in lupus nephritis patients: Relation to renal involvement and disease activity. Egypt Rheumatol. 2016; 38(3): 177–82, CrossRef.
Do Nascimento JF, Canani LH, Gerchman F, Rodrigues PG, Joelsons G, Dos Santos M, et al. Messenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathy. BMC Nephrol. 2013; 14(1): 214, CrossRef.
Li L, Wang J, Li Y, Lu C, Liu Y, Zhang Z, et al. The podocyte count detected by an improved immunocytochemical method has higher diagnostic efficiency than enzyme-linked immunosorbent assay and serum cystatin C to evaluate the early stage damage of glomerular. J Clin Lab Anal. 2017; 31(2): e22029, CrossRef.
Wickman L, Afshinnia F, Wang SQ, Yang Y, Wang F, Chowdhury M, et al. Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. J Am Soc Nephrol. 2013; 24(12): 2081–95, CrossRef.
Rodrigues PG, Bringhenti RN, Do Nascimento JF, Joelsons G, Dos Santos M, Pereira S, et al. Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies. Int J Clin Exp Pathol. 2014; 7(5): 2185–98, PMID.
Navarro-Muñoz M, Ibernon M, Pérez V, Ara J, Espinal A, López D, et al. Messenger RNA expression of B7-1 and NPHS1 in urinary sediment could be useful to differentiate between minimal-change disease and focal segmental glomerulosclerosis in adult patients. Nephrol Dial Transplant. 2011; 26(12): 3914–23, CrossRef.
Szeto CC, Wang G, Chow KM, Lai FMM, Ma TKW, Kwan BCH, et al. Podocyte mRNA in the urinary sediment of minimal change nephropathy and focal segmental glomerulosclerosis. Clin Nephrol. 2015; 84(4): 198–205, CrossRef.
Kostovska I, Trajkovska T, Topuzovska S, Cekovska S, Spasovski G, Kostovski O, et al. Urinary nephrin is earlier, more sensitive and specific marker of diabetic nephropathy than microalbuminuria. J Med Biochem. 2020; 39(1): 83–90, CrossRef.
Hara M, Yanagihara T, Hirayama Y, Ogasawara S, Kurosawa H, Sekine S, et al. Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli. Hum Pathol. 2010; 41(9): 1265–75, CrossRef.
Kanno K, Kawachi H, Uchida Y, Hara M, Shimizu F, Uchiyama M. Urinary sediment podocalyxin in children with glomerular diseases. Nephron Clin Pract. 2003; 95(3): c91–9, CrossRef.
Liu T, Zhang BL, Li L. Clinical significance of determining urinary podocalyxin level in children with primary nephrotic syndrome. Chin J Contemp Pediatr. 2012; 14(5): 332–5, PMID.
Shen P, Shen J, Li W, He L. Urinary podocyte can be an indicator for the pathogenetic condition of patients with IgA nephropathy. Clin Lab. 2014; 60(10): 1709–15, CrossRef.
Hanamura K, Tojo A, Fujita T. Urinary and glomerular podocytes in patients with chronic kidney diseases. Clin Exp Nephrol. 2014; 18(1): 95–103, CrossRef.
Jiang WL, Peng YM, Liu YH, Liu H, Chen GC, Xu XQ, et al. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression. Ren Fail. 2012; 34(7): 821–6, CrossRef.
Lu J, Hu ZB, Chen PP, Lu CC, Zhang JX, Li XQ, et al. Urinary levels of podocyte-derived microparticles are associated with the progression of chronic kidney disease. Ann Transl Med. 2019; 7(18): 445, CrossRef.
DOI: https://doi.org/10.18585/inabj.v15i5.2553
Copyright (c) 2023 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
